30836-96-5 Usage
Uses
Used in Pharmaceutical Industry:
6-Nitroquinoline-2-carboxylic acid is used as an active pharmaceutical ingredient for its antimicrobial properties, contributing to the development of treatments for various infections.
Used in Agrochemical Industry:
In agrochemicals, 6-Nitroquinoline-2-carboxylic acid is utilized as a biocidal agent to protect crops from diseases and pests, thereby enhancing agricultural productivity.
Used in Analytical Chemistry:
6-Nitroquinoline-2-carboxylic acid is employed as a fluorescent probe for detecting certain metal ions, offering a sensitive and selective method for metal ion analysis.
Used in Material Science:
It is used in the development of new materials due to its unique chemical properties, which can contribute to the creation of advanced materials with specific characteristics.
Used in Organic Synthesis:
6-Nitroquinoline-2-carboxylic acid serves as a precursor in organic synthesis, enabling the production of a variety of complex organic compounds for different applications.
Check Digit Verification of cas no
The CAS Registry Mumber 30836-96-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,8,3 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 30836-96:
(7*3)+(6*0)+(5*8)+(4*3)+(3*6)+(2*9)+(1*6)=115
115 % 10 = 5
So 30836-96-5 is a valid CAS Registry Number.
30836-96-5Relevant academic research and scientific papers
Carbapenem antibiotic compounds
-
, (2008/06/13)
The present invention relates to carbapenems and provides a compound of the formula (I) STR1 wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; P1 is of the formula: STR2 and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
